Impact of COVID-19 pandemic on eye cancer care in United Kingdom.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
19
08
2020
accepted:
14
01
2021
revised:
05
01
2021
pubmed:
10
2
2021
medline:
23
4
2021
entrez:
9
2
2021
Statut:
ppublish
Résumé
The COVID-19 pandemic has had an unprecedented impact on the National Health Service in United Kingdom. The UK Ocular Oncology Services evaluated the impact on the adult eye cancer care in the UK. All four adult Ocular Oncology centres participated in a multicentre retrospective review comparing uveal melanoma referral patterns and treatments in a 4-month period during the national lockdown and first wave of the COVID-19 pandemic in 2020 with corresponding periods in previous 2 years. During the national lockdown, referral numbers and confirmed uveal melanoma cases reduced considerably, equalling to ~120 fewer diagnosed uveal melanoma cases compared to previous 2 years. Contrary to the recent trend, increased caseloads of enucleation and stereotactic radiosurgery (p > 0.05), in comparison to fewer proton beam therapy (p < 0.05), were performed. In the 4-month period following lockdown, there was a surge in clinical activities with more advanced diseases (p < 0.05) presenting to the services. As the COVID-19 pandemic continues to mount pressure and reveal its hidden impact on the eye cancer care, it is imperative for the Ocular Oncology Services to plan recovery strategies and innovative ways of working.
Identifiants
pubmed: 33558707
doi: 10.1038/s41416-021-01274-4
pii: 10.1038/s41416-021-01274-4
pmc: PMC8039025
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1357-1360Commentaires et corrections
Type : ErratumIn
Références
The Royal College of Ophthalmologists. Referral pathways for adult ocular tumours. https://www.rcophth.ac.uk/wp-content/uploads/2017/09/Referral-pathways-for-adult-ocular-tumours-June-2017.pdf (2019).
Burr, J. M., Mitry, E., Rachet, B. & Coleman, M. P. Survival from uveal melanoma in England and Wales 1986 to 2001. Ophthalmic Epidemiol. 14, 3–8 (2007).
doi: 10.1080/09286580600977281
Singh, A. D., Turell, M. E. & Topham, A. K. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology 118, 1881–1885 (2011).
doi: 10.1016/j.ophtha.2011.01.040
Mellen, P. L., Morton, S. J. & Shields, C. L. American joint committee on cancer staging of uveal melanoma. Oman J. Ophthalmol. 6, 116–118 (2013).
doi: 10.4103/0974-620X.116652
Skalet, A. H., Allen, R. C., Shields, C. L., Wilson, M. W., Mruthyunjaya, P. & Gombos, D. S. Considerations for the management and triage of ocular oncology cases during the COVID-19 pandemic. Ocul. Oncol. Pathol. 6, 219–222 (2020).
doi: 10.1159/000507734
Manjandavida, F. P., Honavar, S. G., Kim, U., Singh, U., Menon, V., Das, S. et al. Ocular oncology practice guidelines during COVID-19 pandemic—an expert consensus. Indian J. Ophthalmol. 68, 1281–1291 (2020).
doi: 10.4103/ijo.IJO_1669_20
Mishra, K. K., Afshar, A., Thariat, J., Shih, H. A., Scholey, J. E., Daftari, I. K., et al. Practice considerations for proton beam radiation therapy of uveal melanoma during the coronavirus disease pandemic: Particle Therapy Co-Operative Group Ocular Experience. Adv. Radiat. Oncol. http://www.sciencedirect.com/science/article/pii/S2452109420300853 (2020).
Mueller, A. J., Talies, S., Schaller, U. C., Horstmann, G., Wowra, B. & Kampik, A. Stereotactic radiosurgery of large uveal melanomas with the gamma-knife. Ophthalmology 107, 1381–1388 (2000).
doi: 10.1016/S0161-6420(00)00150-0